Berlin - Delayed Quote EUR

Nicox SA (NXOA.BE)

0.2260
-0.0020
(-0.88%)
At close: June 6 at 7:33:02 PM GMT+2
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
7,858.8420
7,858.8420
6,903.2040
5,242
8,583
Cost of Revenue
1,109.7600
1,109.7600
18,406
18,103
1,350
Gross Profit
6,749.0820
6,749.0820
-11,760
-12,861
7,233
Operating Expense
16,485.1460
16,485.1460
20,887.5470
16,510
25,399
Operating Income
-9,736.0640
-9,736.0640
-13,984.3430
-29,371
-18,166
Net Non Operating Interest Income Expense
-1,320.2200
-1,320.2200
-1,142.1330
-859
-4,798
Pretax Income
-22,130.2260
-22,130.2260
-21,358.7570
-31,999
-47,405
Tax Provision
259.4120
259.4120
-477.8340
-504
-3,644
Net Income Common Stockholders
-22,389.6390
-22,389.6390
-20,880.9250
-31,285
-43,761
Diluted NI Available to Com Stockholders
-22,389.6390
-22,389.6390
-20,880.9250
-31,285
-43,761
Basic EPS
-0.24
-0.35
-0.42
-0.62
-1.17
Diluted EPS
-0.24
-0.35
-0.42
-0.62
-1.17
Basic Average Shares
63,143.5270
69,013.3860
49,859.4310
50,100.4480
37,486.5700
Diluted Average Shares
63,143.5270
69,013.3860
49,859.4310
50,100.4480
37,486.5700
Total Operating Income as Reported
-9,853.6460
-9,853.6460
-17,055.9780
-34,061
-46,010
Total Expenses
17,594.9060
17,594.9060
20,887.5470
34,613
26,749
Net Income from Continuing & Discontinued Operation
-22,389.6390
-22,389.6390
-20,880.9250
-31,285
-43,761
Normalized Income
-11,640.8595
-11,640.8595
-17,890.6800
-31,285
-18,135.7440
Interest Income
845.3940
845.3940
1,099.4320
1,120
0
Interest Expense
1,557.3120
1,557.3120
1,633.2630
1,630
2,023
Net Interest Income
-1,320.2200
-1,320.2200
-1,142.1330
-859
-4,798
EBIT
-20,572.9140
-20,572.9140
-19,725.4940
-30,369
-45,382
EBITDA
-20,555.7590
-20,555.7590
-19,704.0250
-18,311
-15,961
Reconciled Cost of Revenue
1,109.7600
1,109.7600
18,406
18,103
1,350
Reconciled Depreciation
17.1550
17.1550
21.4690
11,216
29,421
Net Income from Continuing Operation Net Minority Interest
-22,389.6390
-22,389.6390
-20,880.9250
-31,285
-43,761
Total Unusual Items Excluding Goodwill
-14,331.7060
-14,331.7060
-3,058.6730
0
-27,760
Total Unusual Items
-14,331.7060
-14,331.7060
-3,058.6730
0
-27,760
Normalized EBITDA
-6,224.0530
-6,224.0530
-16,645.3520
-18,311
11,799
Tax Rate for Calcs
0.0003
0.0003
0
0
0.0001
Tax Effect of Unusual Items
-3,582.9265
-3,582.9265
-68.4280
0
-2,134.7440
12/31/2021 - 9/18/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ABRT.CN Albert Labs International Corp.
0.0050
0.00%
 
IMR.BE AC Immune SA
1.7820
+18.80%
 
BT1.BE Bone Therapeutics SA
0.0018
0.00%
 
8EM.BE Editas Medicine Inc
1.5245
-1.33%
 
5CV.HA CureVac NV
3.8120
-0.78%
 
2LB.MU Iovance Biotherapeutics Inc
1.5644
0.00%
 
P0F.F Egetis Therapeutics AB (publ)
0.3285
-5.06%
 
0M4.F Mersana Therapeutics, Inc.
0.2900
+8.78%
 
GYX.F Futura Medical plc
0.0895
-0.56%
 
ALINT.PA IntegraGen SA
0.5220
0.00%